Skip to main content
American Journal of Epidemiology logoLink to American Journal of Epidemiology
. 2021 Jan 11;190(8):1502–1503. doi: 10.1093/aje/kwaa291

Margerison et al. Respond to “Medicaid Policy and Reproductive Autonomy”

Claire E Margerison , Robert Kaestner, Jiajia Chen, Colleen MacCallum-Bridges
PMCID: PMC8327192  PMID: 33423058

Expansion of Medicaid coverage under the Affordable Care Act has increased the percentage of reproductive-age women who report having health insurance by at least 9 percentage points overall, with higher increases among women without dependent children (1, 2). Yet, in our study (3), we found that expanded Medicaid eligibility during the year prior to conception was not associated with improvements in prepregnancy or pregnancy health and did not reduce the prevalence of adverse birth outcomes. These “null” findings are consistent with prior reports that expansion of Medicaid to women during pregnancy also did not reduce the prevalence of adverse birth outcomes (4, 5).

We thank Dr. Jarlenski (6) for her thoughtful comments on our article. We agree with her points regarding the ethical foundation and potential health benefits of reproductive autonomy. Accordingly, we agree that Medicaid should include policies and benefits that ensure such autonomy. We also agree that Medicaid coverage could do more to promote health over the life course, not only for women and infants but for all individuals and families. Decades of public health and policy attempts to improve pregnancy health and outcomes by focusing only on the 9 months of pregnancy have done little to reduce high rates of or disparities in preterm delivery, low birth weight, or maternal mortality in the United States. A paradigm shift within Medicaid to focus on reproductive autonomy over the life course for all individuals, regardless of sex or pregnancy status, would indeed be transformative.

However, our current findings do not necessarily suggest that Medicaid does nothing to promote reproductive autonomy. In fact, our previously published findings (7) (and those of others (811)) showed that the Affordable Care Act’s contraception mandate was associated with increased uptake of prescription contraceptives, particularly long-acting reversible contraceptives (811), but was not associated with unintended pregnancy overall (7). However, among women with government-sponsored insurance, unintended pregnancy did decrease in 2013–2015 as compared with 2008–2010 (7), indicating a potentially important role for government-sponsored health insurance (such as Medicaid) in promoting reproductive autonomy.

We also note that our finding of no association between expanded Medicaid eligibility and health outcomes may not extend to the postpartum period, as Jarlenski pointed out (6). Currently, women with Medicaid coverage during pregnancy lose eligibility 60 days postpartum unless they can requalify under income and/or parental eligibility guidelines. Yet, 11.7% of pregnancy-related deaths occur 43–365 days postpartum (12), and up to 80% of drug-related pregnancy-associated deaths occur in the second half of the postpartum year (13, 14). Extending Medicaid coverage to low-income women after pregnancy could facilitate more continuous care and offer more opportunities to identify and support women struggling with physical complications, mental health symptoms, or substance use. However, simply extending Medicaid coverage with no change in the recommendation that women attend only 1 postpartum visit at 6 weeks may be insufficient. Indeed, the American College of Obstetricians and Gynecologists recommends that postpartum care be an ongoing process rather than a single visit (15).

We share Dr. Jarlenski’s concerns about the limitations (e.g., measurement error) of available data to identify the full consequences of health insurance for preconception and pregnancy health and infant health. We also agree that health is determined only partly by interaction with the medical system as currently constituted, and that insurance thus has limited scope to affect maternal and infant health. We support Dr. Jarlenski’s point that there is a need to broaden the programmatic aspects of Medicaid or to redesign the web of poverty-related programs to address issues of systemic racism, intergenerational poverty, lack of parental leave and affordable child-care policies, unhealthy and unsafe neighborhood conditions, and other structural factors linked to poor pregnancy health and outcomes.

ACKNOWLEDGMENTS

Author affiliations: Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing, Michigan, United States (Claire E. Margerison, Colleen MacCallum-Bridges); Harris School of Public Policy, University of Chicago, Chicago, Illinois, United States (Robert Kaestner); and Department of Economics, College of Liberal Arts and Sciences, University of Illinois at Chicago, Chicago, Illinois, United States (Jiajia Chen).

This research was supported by grant R01HD095951 (“Policy Change and Women’s Health”; Principal Investigator: C.E.M.) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Conflict of interest: none declared.

REFERENCES

  • 1.Margerison  CE, MacCallum  CL, Chen  J, et al.  Impacts of Medicaid expansion on health among women of reproductive age. Am J Prev Med. 2020;58(1):1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Johnston  EM, Strahan  AE, Joski  P, et al.  Impacts of the Affordable Care Act’s Medicaid expansion on women of reproductive age: differences by parental status and state policies. Womens Health Issues. 2018;28(2):122–129. [DOI] [PubMed] [Google Scholar]
  • 3.Margerison  CE, Kaestner  R, Chen  J, et al.  Impacts of Medicaid expansion before conception on prepregnancy health, pregnancy health, and outcomes. Am J Epidemiol. 2021;190(8):1488–1498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Dave  D, Decker  S, Kaestner  R, et al.  Re-examining the effects of Medicaid expansion for pregnant women. (NBER Working Paper no. 14591). Cambridge, MA: National Bureau of Economic Research; 2008. https://www.nber.org/papers/w14591. Accessed October 28, 2020. [Google Scholar]
  • 5.Howell  EM. The impact of the Medicaid expansions for pregnant women: a synthesis of the evidence. Med Care Res Rev. 2001;58(1):3–30. [DOI] [PubMed] [Google Scholar]
  • 6.Jarlenski  M. Invited commentary: Medicaid policy and pregnancy outcomes—toward a reproductive autonomy framework. Am J Epidemiol. 2021;190(8):1499–1501. [DOI] [PubMed] [Google Scholar]
  • 7.MacCallum-Bridges  CL, Margerison  CE. The Affordable Care Act contraception mandate & unintended pregnancy in women of reproductive age: an analysis of the National Survey of Family Growth, 2008–2010 v. 2013–2015. Contraception. 2020;101(1):34–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Snyder  AH, Weisman  CS, Liu  G, et al.  The impact of the Affordable Care Act on contraceptive use and costs among privately insured women. Women’s Health Issues. 2018;28(3):219–223. [DOI] [PubMed] [Google Scholar]
  • 9.Dalton  VK, Carlos  RC, Kolenic  GE, et al.  The impact of cost sharing on women’s use of annual examinations and effective contraception. Am J Obstet Gynecol. 2018;219(1):93.e1–93.e13. [DOI] [PubMed] [Google Scholar]
  • 10.Becker  NV. The impact of insurance coverage on utilization of prescription contraceptives: evidence from the Affordable Care Act. J Policy Anal Manage. 2018;37(3):571–601. [PubMed] [Google Scholar]
  • 11.Carlin  CS, Fertig  AR, Dowd  BE. Affordable Care Act’s mandate eliminating contraceptive cost sharing influenced choices of women with employer coverage. Health Aff. 2016;35(9):1608–1615. [DOI] [PubMed] [Google Scholar]
  • 12.Petersen  EE, Davis  NL, Goodman  D, et al.  Vital signs: pregnancy-related deaths, United States, 2011–2015, and strategies for prevention, 13 states, 2013–2017. MMWR Morb Mortal Wkly Rep. 2019;68(18):423–429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Smid  MC, Stone  NM, Baksh  L, et al.  Pregnancy-associated death in Utah: contribution of drug induced deaths. Obstet Gynecol. 2019;133(6):1131–1140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Schiff  DM, Nielsen  T, Terplan  M, et al.  Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts. Obstet Gynecol. 2018;132(2):466–474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.McKinney  J, Keyser  L, Clinton  S, et al.  ACOG Committee Opinion no. 736: optimizing postpartum care. Obstet Gynecol. 2018;132(3):784–785. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Epidemiology are provided here courtesy of Oxford University Press

RESOURCES